| |
Cervical cytology |
|
Clinicopathologic
Findings (N (%)) |
Negative
136(51.7) |
AGC
64(24.3) |
AC
63(24.0) |
p value
(Negative vs AC) |
| Age |
|
|
|
|
| ＜50 years |
25(54.3) |
12(26.1) |
9(19.6) |
|
| ≧50 years |
111(51.2) |
52(24.0) |
54(24.9) |
N.S. † |
| Stage |
|
|
|
|
| I, II |
120(55.6) |
56(25.9) |
40(18.5) |
|
| III, IV |
16(34.0) |
8(17.0) |
23(48.9) |
<0.001 |
| Histological type |
|
|
|
|
| Endometrioid |
132(53.9) |
60(24.5) |
53(21.6) |
|
| Serous |
2(22.2) |
1(11.1) |
6(66.7) |
|
| Others |
2(22.2) |
3(33.3) |
4(44.4) |
0.003 |
| Grade |
|
|
|
|
| G1,2 |
117(58.2) |
45(22.4) |
39(19.4) |
0.016 ‡ |
| G3 |
15(34.1) |
15(34.1) |
14(31.8) |
0.011 |
| Myometrial invasion |
|
|
|
|
| ＜ 50% |
101(57.1) |
43(24.3) |
33(18.6) |
|
| ≧ 50% |
35(40.7) |
21(24.4) |
30(34.9) |
0.004 |
| Cervical involvement |
|
|
|
|
| Negative |
123(56.4) |
54(24.8) |
41(18.8) |
|
| Positive |
13(28.8) |
10(22.2) |
22(48.9) |
<0.001 |
| Lymph node metastasis |
|
|
|
|
| Negative |
125(54.3) |
58(25.3) |
47(20.4) |
|
| Positive |
8(29.6) |
4(14.8) |
15(55.6) |
0.001 |
| Peritoneal cytology |
|
|
|
|
| Negative |
130(52.6) |
61(23.5) |
56(22.7) |
|
| Positive |
6(37.5) |
3(18.8) |
7(43.8) |
N.S. † |
†; Not significant, ‡; Negative vs. AGC
Multivariate logistic regression analysis |
| |
OR |
(95% CI) |
p value |
|
| Stage (III, IV vs. I, II) |
4.496 |
(2.012-10.049) |
<0.001 |
|
| Cervical involvement |
4.148 |
(1.839-9.353) |
<0.001 |
|
|
